{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:11:36Z","timestamp":1781730696330,"version":"3.54.5"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.semnephrol.2004.04.008","type":"journal-article","created":{"date-parts":[[2004,7,13]],"date-time":"2004-07-13T14:52:47Z","timestamp":1089730367000},"page":"366-378","source":"Crossref","is-referenced-by-count":96,"title":["Nitric oxide, angiotensin II, and hypertension"],"prefix":"10.1016","volume":"24","author":[{"given":"Ming-Sheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne H","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo","family":"Raij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2004.04.008_BIB1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.HYP.34.4.987","article-title":"State-of-the-art lecture. Statins and blockers of the renin-angiotensin system: Vascular protection beyond their primary mode of action","volume":"34","author":"Faggiotto","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB2","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB3","first-page":"H2337","article-title":"Angiotensin receptors","volume":"281","author":"Berry","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.HYP.31.1.342","article-title":"Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide","volume":"31","author":"Ichiki","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.HYP.32.3.527","article-title":"Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland","volume":"32","author":"Usui","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.35.1.155","article-title":"Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function","volume":"35","author":"Carey","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.RES.88.2.229","article-title":"Nitric oxide attenuates signal transduction","volume":"88","author":"Li","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.HYP.8.1.37","article-title":"Crucial role of endothelium in the vasodilator response to increased flow in vivo","volume":"8","author":"Pohl","year":"1986","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"399","author":"Dimmeler","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB10","first-page":"375","article-title":"Guanylyl cyclases and signaling by cyclic GMP","volume":"52","author":"Lucas","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00005344-199912000-00016","article-title":"Nitric oxide as a signaling molecule in the vascular system","volume":"34","author":"Ignarro","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1084\/jem.189.8.1255","article-title":"Increased adhesion and aggregation of platelets lacking cyclic guanosine 3\u2032,5\u2032-monophosphate kinase I","volume":"189","author":"Massberg","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0008-6363(02)00327-9","article-title":"Vasoprotection by nitric oxide","volume":"55","author":"Gewaltig","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.HYP.37.2.767","article-title":"Workshop: Hypertension and cardiovascular risk factors: Role of the angiotensin II-nitric oxide interaction","volume":"37","author":"Raij","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB15","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1177\/14703203010020011001","article-title":"Interaction among angiotensin II, nitric oxide and oxidative stress","volume":"2","author":"Zhou","year":"2001","journal-title":"J Renin Ang Aldosterone Sys"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB16","first-page":"211","article-title":"Nitric oxide\u2014angiotensin II axis in renal and cardiovascular injury","volume":"13","author":"Adam","year":"2000","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB17","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1998.06806.x","article-title":"Angiotensin II, nitric oxide, and end-organ damage in hypertension","volume":"68","author":"Bataineh","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1172\/JCI119156","article-title":"Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats","volume":"99","author":"Takemoto","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.RES.83.7.743","article-title":"Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats","volume":"83","author":"Katoh","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/377239a0","article-title":"Hypertension in mice lacking the gene for endothelial nitric oxide synthase","volume":"377","author":"Huang","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB21","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1172\/JCI4394","article-title":"Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase","volume":"102","author":"Ohashi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.RES.0000020404.01971.2F","article-title":"Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries","volume":"90","author":"Touyz","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.HYP.32.2.331","article-title":"Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts","volume":"32","author":"Pagano","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1523-1755.1998.00068.x","article-title":"Angiotensin II induces superoxide anion production by mesangial cells","volume":"54","author":"Jaimes","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0008-6363(99)00184-4","article-title":"The cardiovascular effects and implications of peroxynitrite","volume":"44","author":"Ronson","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.RES.82.7.810","article-title":"Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide","volume":"82","author":"Wang","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB27","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI118623","article-title":"Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone","volume":"97","author":"Rajagopalan","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB28","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1161\/01.RES.86.9.e85","article-title":"Vascular superoxide production by NAD(P)H oxidase","volume":"86","author":"Guzik","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB29","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMoa013591","article-title":"Endothelial function and oxidative stress in renovascular hypertension","volume":"346","author":"Higashi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB30","first-page":"325","article-title":"Endothelins","volume":"46","author":"Rubanyi","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB31","first-page":"R243","article-title":"Renal endothelin in chronic angiotensin II hypertension","volume":"283","author":"Sasser","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/01.HYP.37.2.505","article-title":"Role of endothelin and isoprostanes in slow pressor responses to angiotensin II","volume":"37","author":"Ortiz","year":"2001","journal-title":"Hypertension"},{"issue":"suppl 7","key":"10.1016\/j.semnephrol.2004.04.008_BIB33","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1097\/00005344-199100177-00075","article-title":"Differential effect of cyclic GMP on the release of endothelin-1 from cultured endothelial cells and intact porcine aorta","volume":"17","author":"Boulanger","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB34","first-page":"F1132","article-title":"Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat","volume":"281","author":"Kramp","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB35","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1046\/j.1523-1755.1999.00466.x","article-title":"Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition","volume":"55","author":"Qiu","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1011448007222","article-title":"Crosstalk between endothelin and nitric oxide in the control of vascular tone","volume":"6","author":"Lavallee","year":"2001","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB37","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.HYP.34.4.876","article-title":"State-of-the-art lecture. Role of endothelin-1 in hypertension","volume":"34","author":"Schiffrin","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.HYP.27.5.1173","article-title":"Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics","volume":"27","author":"Deng","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB39","first-page":"F900","article-title":"EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles","volume":"263","author":"Ohishi","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB40","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/01.HYP.31.6.1255","article-title":"Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension","volume":"31","author":"Ichihara","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB41","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM199405193302008","article-title":"The emerging concept of vascular remodeling","volume":"330","author":"Gibbons","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1152\/physrev.2001.81.3.999","article-title":"Vascular smooth muscle growth","volume":"81","author":"Berk","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB43","first-page":"296","article-title":"Nitric oxide, salt sensitivity, and cardiorenal injury in hypertension","volume":"19","author":"Raij","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB44","first-page":"1967","article-title":"Essential hypertension","volume":"vol 1","author":"Laragh","year":"2000"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB45","first-page":"11","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.HYP.32.2.273","article-title":"Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats","volume":"32","author":"Tomita","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1007897308187","article-title":"Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats","volume":"14","author":"Minamino","year":"2000","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB48","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.HYP.30.6.1621","article-title":"Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade","volume":"30","author":"Takemoto","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB49","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/hy1101.096109","article-title":"Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II","volume":"38","author":"Henrion","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1096\/fj.02-0321fje","article-title":"AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway","volume":"17","author":"Ritter","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.HYP.0000050101.90932.14","article-title":"Cardiac angiotensin II type 2 receptor activates the kinin\/NO system and inhibits fibrosis","volume":"41","author":"Kurisu","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.HYP.29.1.235","article-title":"The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension","volume":"29","author":"Hayakawa","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB53","series-title":"Angiotensin II Receptor Antagonists","first-page":"279","article-title":"Role of AT1 angiotensin receptors in vascular remodeling in hypertension","author":"Schiffrin","year":"2001"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/hy09t1.096249","article-title":"Vascular remodeling in hypertension","volume":"38","author":"Intengan","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB55","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.HYP.37.2.574","article-title":"p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY","volume":"37","author":"Touyz","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB56","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/01.CIR.101.14.1653","article-title":"Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan","volume":"101","author":"Schiffrin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.HYP.23.1.83","article-title":"Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension","volume":"23","author":"Schiffrin","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00004872-199816040-00007","article-title":"Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats","volume":"16","author":"Sharifi","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB59","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.CIR.0000024103.04821.86","article-title":"Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB60","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.92.23.10663","article-title":"The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor","volume":"92","author":"Nakajima","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/hy0102.099025","article-title":"Vessel-specific stimulation of protein synthesis by nitric oxide synthase inhibition","volume":"39","author":"Martens","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/01.HYP.28.2.153","article-title":"Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta","volume":"28","author":"Kato","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB63","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI1699","article-title":"Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling","volume":"101","author":"Rudic","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.ATV.21.2.201","article-title":"Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling","volume":"21","author":"Kawashima","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB65","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.HYP.26.6.957","article-title":"Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats","volume":"26","author":"Numaguchi","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB66","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.ATV.16.10.1256","article-title":"Role of NO in flow-induced remodeling of the rabbit common carotid artery","volume":"16","author":"Tronc","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB67","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1172\/JCI1293","article-title":"Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice","volume":"101","author":"Moroi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB68","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1161\/01.ATV.20.11.e96","article-title":"Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice","volume":"20","author":"Yogo","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB69","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1073\/pnas.92.4.1137","article-title":"Gene therapy inhibiting neointimal vascular lesion","volume":"92","author":"von der Leyen","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.CIR.98.9.919","article-title":"Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs","volume":"98","author":"Varenne","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB71","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/hy1201.099611","article-title":"Oxidative stress in arterial hypertension","volume":"38","author":"Zalba","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB72","series-title":"Angiotensin II Receptor Antagonists","first-page":"235","article-title":"Vascular effects of angiotensin II and AT1 receptor blockade","author":"Grant","year":"2001"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB73","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.32.3.488","article-title":"Role of NADH\/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy","volume":"32","author":"Zafari","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB74","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/hy09t1.093361","article-title":"Intrarenal transport and vasoactive substances in hypertension","volume":"38","author":"Ortiz","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB75","series-title":"Angiotensin II Receptor Antagonists","first-page":"149","article-title":"Interaction of AT1 receptor antagonists and other vasoactive factors","author":"Ahmed","year":"2001"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB76","series-title":"Angiotensin II Receptor Antagonists","first-page":"189","article-title":"Renal actions of angiotensin II and AT1 receptor blockers","author":"Navar","year":"2001"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB77","series-title":"Angiotensin II Receptor Antagonists","first-page":"171","article-title":"Mechanism for chronic antihypertensive effect of angiotensin II blockade","author":"Brands","year":"2001"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB78","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.ASN.0000013292.78621.FD","article-title":"Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors","volume":"13","author":"Peti-Peterdi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB79","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1172\/JCI119531","article-title":"The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats","volume":"100","author":"Siragy","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB80","doi-asserted-by":"crossref","first-page":"74S","DOI":"10.1016\/S0895-7061(01)02073-8","article-title":"Nitric oxide in the control of renal hemodynamics and excretory function","volume":"14","author":"Majid","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB81","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1440-1681.1997.tb02097.x","article-title":"Actions of nitric oxide on renal epithelial transport","volume":"24","author":"Stoos","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB82","first-page":"242","article-title":"Role of nitric oxide in renal hemodynamics","volume":"19","author":"Gabbai","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB83","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.RES.88.3.347","article-title":"Nitric oxide dependency of arterial pressure-induced changes in renal interstitial hydrostatic pressure in dogs","volume":"88","author":"Majid","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB84","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/hy0202.103821","article-title":"Regulation of intrarenal angiotensin II in hypertension","volume":"39","author":"Navar","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.HYP.31.1.271","article-title":"Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation","volume":"31","author":"Zou","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB86","first-page":"R266","article-title":"Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II","volume":"283","author":"Szentivanyi","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB87","first-page":"F365","article-title":"Angiotensin II and renal medullary blood flow in Lyon rats","volume":"284","author":"Sarkis","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB88","first-page":"F315","article-title":"Absence of tubuloglomerular feedback responses in AT1A receptor-deficient mice","volume":"273","author":"Schnermann","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB89","first-page":"F751","article-title":"Tubuloglomerular feedback in ACE-deficient mice","volume":"276","author":"Traynor","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB90","first-page":"251","article-title":"Nitric oxide and tubuloglomerular feedback","volume":"19","author":"Welch","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB91","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.HYP.0000048863.75711.B2","article-title":"Inhibition of apical Na+\/H+ exchangers on the macula densa cells augments tubuloglomerular feedback","volume":"41","author":"Wang","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB92","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(97)05189-1","article-title":"Sodium sensitivity and cardiovascular events in patients with essential hypertension","volume":"350","author":"Morimoto","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.HYP.23.2.195","article-title":"Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors","volume":"23","author":"Bigazzi","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB94","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0895-7061(97)00226-4","article-title":"Impairment of endothelial function in salt-sensitive hypertension in humans","volume":"10","author":"Miyoshi","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB95","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1523-1755.2000.00820.x","article-title":"Inhibition of pressure natriuresis in mice lacking the AT2 receptor","volume":"57","author":"Gross","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB96","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.ASN.0000043904.26730.11","article-title":"Pressure natriuresis in AT(2) receptor-deficient mice with L-NAME hypertension","volume":"14","author":"Obst","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1681\/ASN.V10121","article-title":"Pressure natriuresis in nitric oxide-deficient hypertensive rats","volume":"10","author":"Fortepiani","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB98","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-201x.2002.00937.x","article-title":"Dysregulation of angiotensin II synthesis is associated with salt sensitivity in the spontaneous hypertensive rat","volume":"174","author":"Hodge","year":"2002","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB99","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/01.CIR.96.7.2407","article-title":"Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension","volume":"96","author":"Hayakawa","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB100","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/hc4001.097191","article-title":"Vasopeptidase inhibitors","volume":"104","author":"Corti","year":"2001","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2004.04.008_BIB101","first-page":"S3","article-title":"Angiotensin converting enzyme inhibitors and vascular protection in hypertension","volume":"34","author":"Ruschitzka","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB102","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0008-6363(99)00091-7","article-title":"Interactions among ACE, kinins and NO","volume":"43","author":"Linz","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB103","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.102.3.351","article-title":"Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure","volume":"102","author":"Varin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB104","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.CIR.94.3.258","article-title":"Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease","volume":"94","author":"Mancini","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0735-1097(99)00561-6","article-title":"A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension","volume":"35","author":"Higashi","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB106","first-page":"F410","article-title":"Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin","volume":"275","author":"Lisy","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB107","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.HYP.35.6.1221","article-title":"Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats","volume":"35","author":"Intengan","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB108","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1681\/ASN.V12112280","article-title":"Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension","volume":"12","author":"Quaschning","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB109","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.HYP.37.4.1108","article-title":"Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension","volume":"37","author":"Quaschning","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0895-7061(97)00404-4","article-title":"Effects of omapatrilat in low, normal, and high renin experimental hypertension","volume":"11","author":"Trippodo","year":"1998","journal-title":"Am J Hypertens"},{"issue":"suppl 11","key":"10.1016\/j.semnephrol.2004.04.008_BIB111","first-page":"S104","article-title":"Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats","volume":"10","author":"Bennai","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 11","key":"10.1016\/j.semnephrol.2004.04.008_BIB112","first-page":"S129","article-title":"AT1 receptor blockade in experimental myocardial ischemia\/reperfusion","volume":"10","author":"Jalowy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB113","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1046\/j.1523-1755.2001.0590041257.x","article-title":"AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR","volume":"59","author":"Welch","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB114","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00004872-200202000-00018","article-title":"Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats","volume":"20","author":"Brosnan","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB115","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.103.6.904","article-title":"Angiotensin II type 1 receptor blockers","volume":"103","author":"Burnier","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB116","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB117","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI1500","article-title":"Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells","volume":"101","author":"Hernandez-Perera","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB118","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB119","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.HYP.31.1.225","article-title":"Effects of lipid-lowering agents in the Dahl salt-sensitive rat","volume":"31","author":"Wilson","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB120","series-title":"Calcium Antagonists in Clinical Medicine","author":"Epstein","year":"1998"},{"key":"10.1016\/j.semnephrol.2004.04.008_BIB121","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.97.6.576","article-title":"Amlodipine releases nitric oxide from canine coronary microvessels","volume":"97","author":"Zhang","year":"1998","journal-title":"Circulation"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929504000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929504000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T05:22:13Z","timestamp":1624512133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929504000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0270929504000567"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2004.04.008","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}